CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Health Supplements
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Pharmaceuticals
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Supermarket and Hypermarket
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Pharmacy and Drug store
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Online Provider
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Application
6.2.3. Market size and forecast, by Distribution Channel
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Application
6.2.4.1.2. Market size and forecast, by Distribution Channel
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Application
6.2.4.2.2. Market size and forecast, by Distribution Channel
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Application
6.2.4.3.2. Market size and forecast, by Distribution Channel
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Application
6.3.3. Market size and forecast, by Distribution Channel
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Application
6.3.4.1.2. Market size and forecast, by Distribution Channel
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Application
6.3.4.2.2. Market size and forecast, by Distribution Channel
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Application
6.3.4.3.2. Market size and forecast, by Distribution Channel
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Application
6.3.4.4.2. Market size and forecast, by Distribution Channel
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Application
6.3.4.5.2. Market size and forecast, by Distribution Channel
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Application
6.3.4.6.2. Market size and forecast, by Distribution Channel
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Application
6.4.3. Market size and forecast, by Distribution Channel
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Application
6.4.4.1.2. Market size and forecast, by Distribution Channel
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Application
6.4.4.2.2. Market size and forecast, by Distribution Channel
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Application
6.4.4.3.2. Market size and forecast, by Distribution Channel
6.4.4.4. Australia
6.4.4.4.1. Market size and forecast, by Application
6.4.4.4.2. Market size and forecast, by Distribution Channel
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Application
6.4.4.5.2. Market size and forecast, by Distribution Channel
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Application
6.4.4.6.2. Market size and forecast, by Distribution Channel
6.5. Latin America
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Application
6.5.3. Market size and forecast, by Distribution Channel
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Application
6.5.4.1.2. Market size and forecast, by Distribution Channel
6.5.4.2. Colombia
6.5.4.2.1. Market size and forecast, by Application
6.5.4.2.2. Market size and forecast, by Distribution Channel
6.5.4.3. Argentina
6.5.4.3.1. Market size and forecast, by Application
6.5.4.3.2. Market size and forecast, by Distribution Channel
6.5.4.4. Rest Of La
6.5.4.4.1. Market size and forecast, by Application
6.5.4.4.2. Market size and forecast, by Distribution Channel
6.6. Middle East and Africa
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by Application
6.6.3. Market size and forecast, by Distribution Channel
6.6.4. Market size and forecast, by country
6.6.4.1. Gcc
6.6.4.1.1. Market size and forecast, by Application
6.6.4.1.2. Market size and forecast, by Distribution Channel
6.6.4.2. South Africa
6.6.4.2.1. Market size and forecast, by Application
6.6.4.2.2. Market size and forecast, by Distribution Channel
6.6.4.3. North Africa
6.6.4.3.1. Market size and forecast, by Application
6.6.4.3.2. Market size and forecast, by Distribution Channel
6.6.4.4. Rest Of Mea
6.6.4.4.1. Market size and forecast, by Application
6.6.4.4.2. Market size and forecast, by Distribution Channel
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Catalent, Inc.
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. sirio pharma co., ltd.
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Fuji Capsules Co. Ltd.
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. InovoBiologic Inc
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. NOW Foods Inc.
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Gelita AG.
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Captek Softgel International Inc.
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Viva Pharmaceuticals
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. aenova group
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Procaps Group
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
| ※参考情報 腸溶性ソフトジェルカプセルとは、特に消化管の腸において溶解するように設計されたカプセルの一種です。これらのカプセルは、その特殊なコーティングにより、胃酸に対して耐性を持ち、酸性環境下では溶けずに腸に到達することが可能です。これにより、薬剤や栄養素が腸内で効率的に吸収され、最大限の効果を発揮することが期待できます。 腸溶性ソフトジェルカプセルの種類には、いくつかのバリエーションがあります。一般的には、ゼラチンベースのカプセルに腸溶性ポリマーを施したものが多いです。これにより、カプセルが消化管内の特定のpHレベルに反応し、適切なタイミングで中身を放出できます。また、植物由来の素材を使用したベジタブルカプセルも増えてきており、ベジタリアンやヴィーガンのニーズにも対応しています。 腸溶性ソフトジェルカプセルの主な用途としては、主に医薬品や栄養補助食品に用いられます。例えば、薬剤の中には胃酸によって分解されやすいものや、腸内でのみ効果を発揮するものがあります。これらの薬剤を腸溶性カプセルに封入することで、工夫された薬剤の配合が可能となり、患者にとっての服用の便利さや効果の向上を図ることができます。また、オメガ-3脂肪酸やプロバイオティクスなどの栄養補助食品も、腸での吸収を促すために腸溶性ソフトジェルカプセルに封入されています。 腸溶性ソフトジェルカプセルに関連する技術も進化しています。製造技術としては、コーティング技術が非常に重要です。薬剤を完全に包む層を形成するために、様々なナノコーティング技術やエマルジョン技術が用いられています。これにより、均一なサイズのカプセルを作成することができ、品質の安定性を高めることができます。さらに、最近ではマイクロエンカプulation技術も注目されており、これにより成分がより効果的に吸収されることが期待されています。 腸溶性ソフトジェルカプセルの市場は拡大を続けており、特に高齢化社会の進展により、健康維持や疾病予防のための需要が高まっています。消費者が求める健康食品や医薬品に対して、腸溶性カプセルは効果的かつ利便性の高い選択肢となっています。また、持続可能性への意識の高まりにより、環境に配慮した原材料の使用や、廃棄物削減に向けた取り組みも求められるようになっています。 腸溶性ソフトジェルカプセルは、その特殊な設計によって、消化管での薬剤の放出タイミングを最適化し、効果を最大限に発揮させることができます。これにより、用薬の効果を向上させると同時に、副作用の軽減にも寄与します。特に、特定の疾患状態においては、腸内環境を考慮した個別化医療の一環として、腸溶性のカプセルが注目されています。 総じて、腸溶性ソフトジェルカプセルは、健康や医療の分野において重要な役割を果たしており、今後もさらなる技術革新とともに、その価値が高まっていくことでしょう。これらのカプセルは、より多くの人々にとって利便性の高い解決策を提供し、安全にそして効果的に必要な栄養素や薬剤を届ける手段として、ますます重要になっていくことが期待されます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
